4//SEC Filing
Lewicki John A. 4
Accession 0001140361-17-038566
CIK 0001302573other
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 6:35 PM ET
Size
7.5 KB
Accession
0001140361-17-038566
Insider Transaction Report
Form 4
Lewicki John A.
EVP & Chief Scientific Officer
Transactions
- Sale
Common Stock
2017-10-10$4.26/sh−46$196→ 71,614 total - Sale
Common Stock
2017-10-10$4.24/sh−1,202$5,099→ 70,412 total
Holdings
- 88,951(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock unit ("RSU") award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes.
- [F2]Includes 56,875 RSUs. The Reporting Person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof.
- [F3]The shares are held by John Allan Lewicki and Jenniffer Joan Lewicki, Trustees of the Lewicki Family Trust dated December 6, 2000.
Documents
Issuer
OncoMed Pharmaceuticals Inc
CIK 0001302573
Entity typeother
Related Parties
1- filerCIK 0001553352
Filing Metadata
- Form type
- 4
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 6:35 PM ET
- Size
- 7.5 KB